Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.15 (13.043%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.225
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered

6 Feb 2019 14:06

Hardman & Co Research Hardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered 06-Feb-2019 / 14:05 GMT/BST


Hardman & Co Research: Trading very difficult; forecasts lowered

Prospects are very uncertain, and cost reduction measures are being implemented. However, the group continues to develop its product offering to the automobile turbocharger industry through development of its main operational facilities. The recent technical problems at the new machine shop are now resolved, and Chamberlin remains on track strategically. The recent disposal of Exidor has financially de-risked the group, and the shares remain attractively valued against the peer group on most methodologies.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/trading-very-difficult-forecasts-lowered/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Paul Singer +44 20 7194 7622 ps@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

773161 06-Feb-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
21st Feb 20227:00 amRNSHolding(s) in Company
18th Feb 202210:30 amRNSResult of General Meeting and Total Voting Rights
2nd Feb 20227:00 amRNSProposed Placing and Subscription and Notice of GM
5th Jan 202212:15 pmRNSResult of AGM
4th Jan 20227:00 amRNSContract Award
21st Dec 20217:00 amRNSHalf-year Report
30th Nov 202111:01 amRNSFinal Results
16th Sep 20217:00 amRNSPublication of Audited Accounts and Trading Update
30th Jul 20217:00 amRNSHolding(s) in Company
9th Jul 20217:00 amRNSOperational Update
8th Jul 20217:00 amRNSHolding(s) in Company
8th Jun 20212:45 pmRNSResult of AGM
1st Jun 20217:00 amRNSDirectorate Change
28th May 20218:00 amRNSDirectorate Change
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
19th May 20219:05 amRNSSecond Price Monitoring Extn
19th May 20219:00 amRNSPrice Monitoring Extension
19th May 20217:00 amRNSOperational Update
14th May 20212:15 pmRNSChange of Accounting Reference Date
14th May 20217:00 amRNSGrant of Options
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20212:05 pmRNSSecond Price Monitoring Extn
11th May 20212:00 pmRNSPrice Monitoring Extension
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
7th May 20217:00 amRNSDirectorate Change
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSDirectorate Change
20th Apr 20214:10 pmEQSHardman & Co Research: Chamberlin (CMH): Getting back into shape
16th Apr 20217:30 amRNSRestoration - Chamberlin Plc
16th Apr 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSHalf-year Report
13th Apr 20215:04 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFurther re Publication of Accounts
1st Apr 20217:00 amRNSTotal Voting Rights
30th Mar 20215:55 pmRNSHolding(s) in Company
30th Mar 20214:03 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSPlacing, Subscription and Trading Update
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.